Source comparison
Stacking BPC-157 TB-500 ACL Recovery: [Peptide Stack] Comparison
BPC-157 Solo VEGF upregulation, localized collagen synthesis 250–500mcg/day SC $250–$400 Preclinical + case series Effective for localized repair but misses systemic inflammation control. Leaves half the pathway unaddressed TB-500 Solo Actin-binding, systemic
This comparison does not assign a generated winner or score.
- BPC-157 Solo
- VEGF upregulation, localized collagen synthesis
- 250–500mcg/day SC
- $250–$400
- Preclinical + case series
- Effective for localized repair but misses systemic inflammation control. Leaves half the pathway unaddressed
- TB-500 Solo
- Actin-binding, systemic anti-inflammatory, cell migration
- 2–5mg 2x/week SC
- $400–$600
- Preclinical + observational
- Strong systemic repair support but slower collagen deposition than BPC-157. Better for multi-site soft tissue injury than isolated ligament
- BPC-157 + TB-500 Stack
- Dual pathway: localized angiogenesis + systemic inflammation modulation
- BPC daily + TB twice weekly
- $600–$900
- Case series + retrospective cohort
- Most comprehensive approach for ACL recovery. Addresses both structural repair and inflammatory resolution through non-overlapping mechanisms
- GH Secretagogues (MK-677, GHRP-2)
- IGF-1 upregulation, general anabolic signaling
- Daily oral or SC
- $300–$500
- Mixed. Some RCT data for bone/muscle, minimal ligament-specific
- Indirect collagen support through IGF-1 but lacks targeted localization. Best as adjunct to direct repair peptides, not replacement